California 2023-2024 Regular Session

California Assembly Bill AB2761

Introduced
2/15/24  
Introduced
2/15/24  
Refer
3/21/24  
Refer
3/21/24  
Report Pass
4/1/24  
Report Pass
4/1/24  
Refer
4/2/24  
Refer
4/2/24  
Report Pass
4/10/24  
Report Pass
4/10/24  
Refer
4/10/24  
Refer
4/10/24  
Report Pass
4/16/24  
Report Pass
4/16/24  
Refer
4/16/24  
Refer
4/16/24  
Refer
5/1/24  
Refer
5/1/24  
Report Pass
5/16/24  
Report Pass
5/16/24  
Engrossed
5/22/24  
Engrossed
5/22/24  
Refer
5/23/24  
Refer
6/5/24  
Refer
6/5/24  
Report Pass
6/6/24  
Report Pass
6/6/24  
Refer
6/6/24  

Caption

Product safety: plastic packaging: Reducing Toxics in Packaging Act.

Impact

The implementation of AB 2761 underscores a significant shift in California's regulatory landscape concerning public health and product safety. By banning plastic packaging containing PFAS and PVC, the bill aims to foster healthier environmental conditions and reduce the state's reliance on harmful chemicals in everyday consumer goods. Additionally, the act sets a legal framework for civil penalties against violators, reflecting a stricter stance on compliance with environmental health regulations.

Summary

Assembly Bill 2761, known as the Reducing Toxics in Packaging Act, seeks to regulate the use of certain harmful chemicals in plastic packaging throughout California. The bill specifically targets the prohibition of plastic packaging that contains regulated perfluoroalkyl and polyfluoroalkyl substances (PFAS) and polyvinyl chloride (PVC) starting January 1, 2026. The act aims to enhance public health and safety by mitigating exposure to these toxic substances commonly found in various consumer products, promoting safer alternatives across the state.

Sentiment

Sentiment around AB 2761 appears to be largely supportive among public health advocates and environmentalists, who view the legislation as a positive step towards addressing chemical safety in consumer products. However, there are concerns among businesses that rely on traditional plastic packaging materials, which may pose challenges in terms of compliance and cost. Overall, legislative discussions reflect a commitment to public health while navigating the complexities of industrial impact and the economy.

Contention

Points of contention regarding the bill center on the exclusion of certain products from the ban, particularly those used in the medical and pharmaceutical sectors. Critics argue that while the intent to limit harmful substances is commendable, the specific exclusions may create loopholes that could undermine the overall effectiveness of the bill. Additionally, there’s a discussion around the feasibility of enforcing such regulations and the potential economic burden on manufacturers transitioning to compliant materials.

Companion Bills

No companion bills found.

Similar Bills

CA AB1290

Product safety: plastic packaging: substances.

CA AB2247

Perfluoroalkyl and polyfluoroalkyl substances (PFAS) and PFAS products and product components: publicly accessible data collection interface.

NV SB76

Establishes provisions governing certain products that contain intentionally added perfluoroalkyl and polyfluoroalkyl substances. (BDR 52-291)

CA AB872

Environmental health: product safety: perfluoroalkyl and polyfluoroalkyl substances.

NV SB76A

Establishes provisions governing certain products that contain intentionally added perfluoroalkyl and polyfluoroalkyl substances. (BDR 52-291)

RI S0196

Comprehensive Pfas Ban Act Of 2023

RI S2152

Enacts the Comprehensive PFAS Ban Act of 2024, prohibiting the intentional addition of perfluoroalkyl and polyfluoroalkyl substances of PFAS in products offered for sale or manufactured in the state as of January 1, 2027.

RI H5673

Comprehensive Pfas Ban Act Of 2023